The MET oncogene, a crucial regulator of the genetic program known as "invasive growth" or "epithelial-mesenchymal transition," has recently emerged as a functional marker of glioblastoma stem cells. Here, we review findings that associate MET expression and activity with a specific, genetically defined glioblastoma stem cell subtype, and data showing how MET sustains the stem cell phenotype in glioblastoma and other tumors. Finally, we discuss issues related to identification of tumorigenic clones driven by MET in the context of genetically heterogeneous tumors and strategies aimed at eradicating cancer stem cells.
The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target.
BOCCACCIO, Carla;COMOGLIO, Paolo
2013-01-01
Abstract
The MET oncogene, a crucial regulator of the genetic program known as "invasive growth" or "epithelial-mesenchymal transition," has recently emerged as a functional marker of glioblastoma stem cells. Here, we review findings that associate MET expression and activity with a specific, genetically defined glioblastoma stem cell subtype, and data showing how MET sustains the stem cell phenotype in glioblastoma and other tumors. Finally, we discuss issues related to identification of tumorigenic clones driven by MET in the context of genetically heterogeneous tumors and strategies aimed at eradicating cancer stem cells.File | Dimensione | Formato | |
---|---|---|---|
Cancer research_2013_aperto.pdf
Open Access dal 23/05/2014
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
610.23 kB
Formato
Adobe PDF
|
610.23 kB | Adobe PDF | Visualizza/Apri |
Boccaccio&Comoglio_Cancer Research 2013.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
514.28 kB
Formato
Adobe PDF
|
514.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.